Endo180 modulation by bisphosphonates and diagnostic accuracy in metastatic breast cancer

被引：0
|
作者：
C Palmieri
M P Caley
K Purshouse
A-V Fonseca
M Rodriguez-Teja
G Kogianni
L Woodley
J Odendaal
K Elliott
J Waxman
J Sturge
机构：
[1] Cancer Research UK Laboratories,Department of Surgery and Cancer
[2] Imperial College London,Department of Medical Oncology
[3] Imperial College Healthcare NHS Trust,Department of Biological Sciences (Biomedical Science)
[4] Charing Cross Hospital,undefined
[5] The Allam Building,undefined
[6] University of Hull,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
bisphosphonates; bone metastasis; breast cancer; collagen receptor; diagnostic marker; plasma marker;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 169
页数：6
相关论文
共 50 条
  • [21] Increased expression of the collagen internalization receptor uPARAP/Endo180 in the stroma of head and neck cancer
    Sulek, Jay
    Wagenaar-Miller, Rebecca A.
    Shireman, Jessica
    Molinolo, Alfredo
    Madsen, Daniel H.
    Engelholm, Lars H.
    Behrendt, Niels
    Bugge, Thomas H.
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2007, 55 (04) : 347 - 353
  • [22] Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces
    Matthew P. Caley
    Helen King
    Neel Shah
    Kai Wang
    Mercedes Rodriguez-Teja
    Julian H. Gronau
    Jonathan Waxman
    Justin Sturge
    Clinical & Experimental Metastasis, 2016, 33 : 151 - 165
  • [23] Tumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces
    Caley, Matthew P.
    King, Helen
    Shah, Neel
    Wang, Kai
    Rodriguez-Teja, Mercedes
    Gronau, Julian H.
    Waxman, Jonathan
    Sturge, Justin
    CLINICAL & EXPERIMENTAL METASTASIS, 2016, 33 (02) : 151 - 165
  • [24] Pancreatic stellate cells reorganize matrix components and lead pancreatic cancer invasion via the function of Endo180
    Koikawa, Kazuhiro
    Ohuchida, Kenoki
    Takesue, Shin
    Ando, Yohei
    Kibe, Shin
    Nakayama, Hiromichi
    Endo, Sho
    Abe, Toshiya
    Okumura, Takashi
    Horioka, Kohei
    Sada, Masafumi
    Iwamoto, Chika
    Moriyama, Taiki
    Nakata, Kohei
    Miyasaka, Yoshihiro
    Ohuchida, Riichi
    Manabe, Tatsuya
    Ohtsuka, Takao
    Nagai, Eishi
    Mizumoto, Kazuhiro
    Hashizume, Makoto
    Nakamura, Masafumi
    CANCER LETTERS, 2018, 412 : 143 - 154
  • [25] Targeting a novel bone degradation pathway in primary bone cancer by inactivation of the collagen receptor uPARAP/Endo180
    Engelholm, Lars H.
    Melander, Maria C.
    Hald, Andreas
    Persson, Morten
    Madsen, Daniel H.
    Jurgensen, Henrik J.
    Johansson, Kristina
    Nielsen, Christoffer
    Norregaard, Kirstine S.
    Ingvarsen, Signe Z.
    Kjaer, Andreas
    Trovik, Clement S.
    Laerum, Ole D.
    Bugge, Thomas H.
    Eide, Johan
    Behrendt, Niels
    JOURNAL OF PATHOLOGY, 2016, 238 (01): : 120 - 133
  • [26] Review of oral and intravenous bisphosphonates in metastatic breast cancer
    Body, JJ
    JOURNAL OF BONE AND MINERAL RESEARCH, 2005, 20 : P18 - P19
  • [27] Update on the role of bisphosphonates in metastatic breast cancer - Introduction
    Lipton, A
    Coleman, RE
    Diel, IJ
    Mundy, G
    SEMINARS IN ONCOLOGY, 2001, 28 (04) : 1 - 1
  • [28] Recent developments in bisphosphonates for patients with metastatic breast cancer
    Gainford, MC
    Dranitsaris, G
    Clemons, M
    BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7494): : 769 - 773
  • [29] Cost of intravenous administration of bisphosphonates in patients with metastatic breast cancer
    Lundkvist, J.
    Kasteng, F.
    Lindman, H.
    Wilking, N.
    VALUE IN HEALTH, 2007, 10 (06) : A335 - A335
  • [30] Endo180 expression with cofunctional partners MT1-MMP and uPAR-uPA is correlated with prostate cancer progression
    Kogianni, Giolanta
    Walker, Marjorie M.
    Waxman, Jonathan
    Sturge, Justin
    EUROPEAN JOURNAL OF CANCER, 2009, 45 (04) : 685 - 693
12345